Pipeline 2021 status PROGRAM DISEASE DISCOVERY DEVELOPMENT PHASE 1B PHASE 2 PHASE 3 Memory NK AML, MDS WU-NK-101 WU-NK WU-NK-101 Solid Tumors WU-NK-201 WU-CART-007 WU-CART T-ALL, T-NHL WU-CART-002 WU-ALLO-1 WU-ALLO AML, MDS WU-ALLO-2 WU-ALLO-3 AML = Acute Myeloid LeukemiaMDS = Myelodysplastic syndromeT-ALL = T-cell Acute Lymphoblastic LeukemiaT-NHL = T-cell Non-Hodgkin’s Lymphoma Next in our story Press Releases